| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Navelbine (vinorelbine tartrate) Injection. SmithKlineBeecham 20-388/S-010 10/2/01 7/24/03 4/23/03 Navelbine (vinorelbine tartrate) Injection. SmithKlineBeecham 20-388/S-014 11/5/02 11/18/02 11/8/02 Navelbine (Vinorelbine) Injection, Glaxo Wellcome NDA 20-388/S8 Vinorelbine Tartrate Injection, 10 mg, Gensia Sicor ANDA 76-028 2/3/03 Vinorelbine Tartrate Injection, 10 mg, Tentative Approval - September 17, 2002 Gensia Sicor ANDA 76-028 9/17/02 Vinorelbine Tartrate Injection, ESI Lederle ANDA 75-992 VINORELBINE TARTRATE Injection 10MG BASE/ML VINORELBINE TARTRATE ESI LEDERLE 076028 VINORELBINE TARTRATE Injection 10MG BASE/ML VINORELBINE TARTRATE GENSIA SICOR 020388 VINORELBINE TARTRATE Injection 10MG BASE/ML NAVELBINE GLAXOSMITHKLINE |
|
© 2009 Betterchem.com
|